I forgot a couple of other key points. The Pivotal phase 3 US study for use of Cytosorb in cardiac surgery is underway, a Hemodefend trial should be starting in the next year and the German Federal Ministry of Education and Research funded study for Cardiac Surgery Patients With Infective Endocarditis has also started.